- Home
- CISO vs CASI Comparison
CISO vs CASI Comparison
Compare CISO & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISO
- CASI
- Stock Information
- Founded
- CISO 2015
- CASI 1991
- Country
- CISO United States
- CASI China
- Employees
- CISO N/A
- CASI N/A
- Industry
- CISO Computer Software: Prepackaged Software
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- CISO Technology
- CASI Health Care
- Exchange
- CISO Nasdaq
- CASI Nasdaq
- Market Cap
- CISO 31.4M
- CASI 35.8M
- IPO Year
- CISO N/A
- CASI 1996
- Fundamental
- Price
- CISO $1.29
- CASI $2.10
- Analyst Decision
- CISO
- CASI Strong Buy
- Analyst Count
- CISO 0
- CASI 1
- Target Price
- CISO N/A
- CASI $4.00
- AVG Volume (30 Days)
- CISO 610.4K
- CASI 384.8K
- Earning Date
- CISO 08-14-2025
- CASI 11-13-2025
- Dividend Yield
- CISO N/A
- CASI N/A
- EPS Growth
- CISO N/A
- CASI N/A
- EPS
- CISO N/A
- CASI N/A
- Revenue
- CISO $28,792,765.00
- CASI $31,564,000.00
- Revenue This Year
- CISO N/A
- CASI N/A
- Revenue Next Year
- CISO N/A
- CASI N/A
- P/E Ratio
- CISO N/A
- CASI N/A
- Revenue Growth
- CISO N/A
- CASI 36.64
- 52 Week Low
- CISO $0.30
- CASI $1.09
- 52 Week High
- CISO $3.84
- CASI $7.55
- Technical
- Relative Strength Index (RSI)
- CISO 72.95
- CASI 47.56
- Support Level
- CISO $0.86
- CASI $2.18
- Resistance Level
- CISO $1.32
- CASI $2.49
- Average True Range (ATR)
- CISO 0.09
- CASI 0.18
- MACD
- CISO 0.04
- CASI -0.05
- Stochastic Oscillator
- CISO 91.23
- CASI 9.95
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.